Opening Asia for Russia

Kazakhstan approves Sputnik M vaccine for teenagers

23.02.2022 92 просмотров

RDIF clarified that Kazakhstan was the first foreign state to approve the use of this drug.


Kazakhstan has become the first foreign country to approve the use of the Russian vaccine against coronavirus for adolescents Sputnik M, the Russian Direct Investment Fund (RDIF) said.

“RDIF announces the decision of the Ministry of Health of the Republic of Kazakhstan to approve the use of the Russian vaccine against coronavirus "Sputnik M" for adolescents aged 12-17 years. Thus, Kazakhstan has become the first foreign state to approve the use of Sputnik M, the report says.

"Sputnik M" adapted by the N.I. NF Gamalei specifically for teenagers.

Sputnik M is a two-component drug similar to the Sputnik V vaccine. The only difference between Sputnik M and Sputnik V is the concentration of adenoviral particles reduced by five times, due to which adolescent immunity is less stressed compared to the dosage for adults.

The Ministry of Health of the Russian Federation registered Sputnik M on November 24 2021 based on clinical studies that confirmed the high safety and immunogenicity profile of this vaccine in adolescents. No serious adverse events associated with Sputnik M vaccination have been identified in participants during the studies. The results correspond to the data obtained in the framework of studies and the use of the Sputnik V preparation for vaccination of the adult population.

Новости партнёров